356 related articles for article (PubMed ID: 1983390)
1. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of relapse following neuroleptic withdrawal.
Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
Apud JA; Egan MF; Wyatt RJ
Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
[TBL] [Abstract][Full Text] [Related]
4. Skin conductance responding in schizophrenic patients with abnormal involuntary movements.
Mintz M; Alfisi S; Sigal M
Psychiatry Res; 1990 Oct; 34(1):19-27. PubMed ID: 1980017
[TBL] [Abstract][Full Text] [Related]
5. The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.
Glazer WM; Morgenstern H; Doucette JT
Br J Psychiatry; 1991 Jun; 158():822-8. PubMed ID: 1678663
[TBL] [Abstract][Full Text] [Related]
6. A 10-year follow-up study of tardive dyskinesia.
Yassa R; Nair NP
Acta Psychiatr Scand; 1992 Oct; 86(4):262-6. PubMed ID: 1360742
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
8. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand.
Caligiuri MP; Lohr JB
J Neuropsychiatry Clin Neurosci; 1990; 2(4):395-8. PubMed ID: 1983784
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic-induced respiratory dyskinesia.
Kruk J; Sachdev P; Singh S
J Neuropsychiatry Clin Neurosci; 1995; 7(2):223-9. PubMed ID: 7626967
[TBL] [Abstract][Full Text] [Related]
11. Familial occurrence of tardive dyskinesia.
Müller DJ; Schulze TG; Knapp M; Held T; Krauss H; Weber T; Ahle G; Maroldt A; Alfter D; Maier W; Nöthen MM; Rietschel M
Acta Psychiatr Scand; 2001 Nov; 104(5):375-9. PubMed ID: 11722319
[TBL] [Abstract][Full Text] [Related]
12. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
[TBL] [Abstract][Full Text] [Related]
13. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
Chiu H; Lau J; Lam L; Shum P
Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
[TBL] [Abstract][Full Text] [Related]
14. Predictors of the course of tardive dyskinesia in patients receiving neuroleptics.
Bergen J; Kitchin R; Berry G
Biol Psychiatry; 1992 Oct; 32(7):580-94. PubMed ID: 1360260
[TBL] [Abstract][Full Text] [Related]
15. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
Friedman JH
Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
[TBL] [Abstract][Full Text] [Related]
16. Treatment of tardive dyskinesia with donepezil: a pilot study.
Caroff SN; Campbell EC; Havey J; Sullivan KA; Mann SC; Gallop R
J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia and positive symptoms of schizophrenia.
White T; Brown KW; Woods JP
Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
[TBL] [Abstract][Full Text] [Related]
18. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
[TBL] [Abstract][Full Text] [Related]
19. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
Glazer WM; Bowers MB; Charney DS; Heninger GR
Biol Psychiatry; 1989 Jul; 26(3):224-33. PubMed ID: 2568132
[TBL] [Abstract][Full Text] [Related]
20. Buspirone in the treatment of tardive dyskinesia.
Moss LE; Neppe VM; Drevets WC
J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]